United States Autoimmune Disorders Diagnostics Market Report

7/23/2019 United States Autoimmune Disorders Diagnostics Market Report

http://slidepdf.com/reader/full/united-states-autoimmune-disorders-diagnostics-market-report 1/11

India Adhesives MarketForecast & Opportunities , 2020

U n i t e d S t a t e s A u to i m m u n e D i s o r d e r s D i a g n o s t i c sM a r k e t O p p o r t u n i t i e s , 2 0 2 0

P h a r m a & H e a l t h c a r e C o n s u l t a n t s



2

7

R e s e a r c h M e t h o d o l o g y

Primary Sources

•Identifying Key Opinion Leaders•Questionnaire Design

•In-depth Interviews

•Coverage across Value Chain market

Market Estimation & Forecasting

Bottom-Up or Top-down approach for Market size estimation

Historical trend examination

Impact analysis of drivers and challenges to market growth

Statistical evaluation to develop the actual forecast

Data Validation, Analysis and Interpretation

Data validation through Primary & Secondary outreach, data analysis andinterpretation of key findings

Data Collection

Qualitative and Quantitative Research

United States AutoimmuneDisorders Diagnostics Market

Secondary Sources

•Government websites•Company annual reports, whitepapers, investor presentations andfinancial reports

© Pharmaion

2015E 2016F 2017F 2018F 2019F 2020F

CAGR (2015E-2020F): XX%



3


© Pharmaion

Baseline Methodology:

For the study of United States autoimmune disorders diagnostics market, Pharmaion has gathered information

through an exhaustive search of credible databases prudently evaluated all the collected information and presented

it in the most accurate and detailed manner.

Primary Research

Key Stakeholders:

Product/Brand Managers

Business DevelopmentManagers

Regional Mangers

Regulatory Affairs Personnel

Marketing & Sales Managers

Head of Patient Support

Programme

Substantial data points for analysis,interpretation and market size estimation

DataTriangulation

(Datavalidation

through crossverification

from primary

& secondarysources)

Qualitative andquantitative datafrom company

website, financial

reports, researcharticles, designedquestionnaires

etc.

In-depthinterviews of keystakeholders of

major companies

Secondary Research

Analysis of Data from crediblesources: Centers for Disease Control

and Prevention (CDC) WHO Reports American Autoimmune

Related Diseases Association(AARDA)

American College of Rheumatology

National Institute of Arthritisand Musculoskeletal and SkinDiseases



4


United States Autoimmune Disorders Diagnostics Market - Market Size Estimation

United States autoimmune disorders diagnostics market has been segmented into two segments:

systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics. Further, the United States autoimmune disorders diagnostics market has been categorized into seven

sub-segments: Anti-Nuclear Antibody Test, Complete Blood Count Test, Erythrocyte Sedimentation Rate(ESR), C-reactive protein, Comprehensive Metabolic Panel, Urinalysis and Others

Anti-Nuclear antibody tests market have been further classified into three sub segments: ENA Panel,Anti-dsDNA and Others (Anticentromere Antibody, Histone Antibody, Nucleolar Antibody, etc.).

Calculation of market size ofthe US autoimmune

disorders diagnosticsmarket

Calculation of Sub-segment market

size

Calculationof regional

marketsize

T o p - d o w n A p p r o a c h

CAGR of forecast period obtained from the

primary and secondary outreach applied onthe given market

By Target Disease, Test & Technology MarketSize = Respective Market Share (From

Primary and Secondary Research) X TotalMarket Value

Regional Market Size = Respective MarketShare (From Primary and Secondary

Research) X Total Market Value

© Pharmaion



T a b l e o f C o n t e n t s

5

© Pharmaion

S No. Contents

1. Autoimmune Disorders Diagnostics Overview

2. Research Methodology

3. Analyst View

4. Disease Epidemiology

4. Global Autoimmune Disorders Diagnostics Market Overview

5. United States Autoimmune Disorders Diagnostics Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Target Disease (Systemic Autoimmune Disorders Diagnostics & Localized Autoimmune

Disorders Diagnostics)

5.2.2. By Test (Urinalysis, Comprehensive Metabolic Panel, C-reactive Protein, Erythrocyte

Sedimentation Rate, Complete Blood Count, Anti-Nuclear Antibody Test & Others)

5.2.3. By Technology (Enzyme Immunoassay, Multiplexed Immunoassays, Immunofluorescence &

Others)

5.2.4. By Region (South-West, West, North-East, Midwest, South-East)

6. United States Anti-Nuclear Antibody Test Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type {Others (Anti-centromere Antibodies, Histone Antibody & Nucleolar Antibody), Anti-

dsDNA Test & ENA Panel}

7. Market Dynamics

7.1. Drivers

7.2. Challenges



T a b l e o f C o n t e n t s

S No. Contents

8. Market Trends & Developments

8.1. Increasing Use of Biomarkers

8.2. Lab automation

8.3. Lab-on- Chip Device

8.4. Portable Diagnostic Equipment

8.5. Partnership with Physician and Diagnostic Laboratories

9. Policy & Regulatory Landscape

10. United States Economic Profile

11. Competitive Landscape

11.1. Competition Benchmarking (Market Attractiveness)

11.2. Company Profiles

11.2.1. Bio-Rad Laboratories, Inc.

11.2.2. Roche Diagnostics Corporation

11.2.3. Abbott Laboratories

11.2.4. Danaher Corporation

11.2.5. Siemens Healthcare Diagnostics, Inc.

11.2.6. Biomeriux Clinical Diagnostics

11.2.7. Immco Diagnostics

11.2.8. Beckton Dickson

11.2.9. Alere Inc.

11.2.10. Inova Diagnostics, Inc.

12. Strategic Recommendations

13. About Us & Disclaimer 3© Pharmaion



I n d u s t r y B r i e f

7© Pharmaion

United States Autoimmune Disorders Diagnostics Market to Surpass US$ 6 Billion by 2020

Growing prevalence of autoimmune disorders and various ongoing technological advancements to drive theUnited States autoimmune disorders diagnostics market

According to recently published Pharmaion report, “United States Autoimmune Disorders DiagnosticsMarket Opportunities, 2020”,the autoimmune disorders diagnostics market in the United States isanticipated to cross US$ 6 billion by 2020. Some of the major autoimmune diseases include RheumatoidArthritis, Type 1 Diabetes, Multiple Sclerosis, Systemic Lupus Erythematosus (SLE), Inflammatory BowelDisease (IBD), Psoriasis and Autoimmune Thyroiditis, etc. According to American Autoimmune RelatedDiseases Association (AARDA), 50 million Americans are suffering from more than 100 types of autoimmune disorders, and 75-85% of the total autoimmune disorders patients in the country are women.

Growth in the market is anticipated on account of growing disease burden of various autoimmunedisorders, increasing healthcare expenditure and various ongoing technological advancements. Moreover,increasing automation in laboratories leading to precise and faster diagnosis is forecast to further fuel themarket of autoimmune disorders diagnostics in the United States during 2015 - 2020.On the basis of targetdisease, the market is broadly segmented into two categories, namely, systemic autoimmune disordersdiagnostics and localized autoimmune disorders diagnostics. Among these two categories, systemicautoimmune disorders diagnostics segment dominated the United States autoimmune disorders diagnosticsmarket in 2014, and the segment is anticipated to continue its dominance through 2020 on account of

increasing ongoing research activities that are focused on developing tests and technologies that wouldprecisely detect the abnormalities in organ functioning and deliver faster diagnosis.

“With growing adoption of biomarkers, Lab-on-Chip devices and portable diagnostic equipment, the marketfor autoimmune disorders diagnostics in the United States is anticipated to grow over the next five years.Moreover, National Institute of Allergy and Infectious Diseases (NIAID) is organizing a clinical researchprogram - Autoimmunity Centre of Excellence (ACEs) for effective diagnosis and treatment of autoimmunediseases by expanding collaborative research across medical specialties, scientific disciplines, and basic & clinical scientists.", said Mr. Karan Chechi, Research Director of Pharmaion, a research based globalpharmaceutical and healthcare consulting firm.



Autoimmune disorders occur when a person’s immune system attacks his/her own body; and for detecting

these disorders and prescribing required treatments, various laboratory tests are performed. On the basis of

disorder type, autoimmune disorders diagnostics market in the US has been segmented into two categories,

namely, systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics.

P r o d u c t O v e r v i e w

Autoimmune Disorders Diagnostics Market

Systemic AutoimmuneDisorders Diagnostics

Localised AutoimmuneDisorders Diagnostics

Systemic Autoimmune Disorders Diagnostics: They are non-organ specific disease which affects multiple

organs and tissues of the body is known as systematic autoimmune disorder. It broadly involves the diagnosis

of diseases, such as Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis, Ankylosing Spondylitis, etc.,which are mainly diagnosed by rheumatologists and clinical immunologists.

Localised Autoimmune Disorders Diagnostics: They are organ specific disease which effects single organ

or tissue of the body and are diagnosed mainly by rheumatologists, endocrinologists and neurologists. It

mainly involves the diagnosis of diseases like Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Type 1

Diabetes, Thyroid, etc.

6© Pharmaion



9

AutoimmuneDisorder

Annual Cost* perPatient (USD)

X X

X X

X X

X X

X X

50

100

150

Diabetes Type 1 Systemic LupusErthymatosus (SLE)

Rheumatoid Arthritis

United States Autoimmune Disorders Prevalence per

100,000 Population, 2013

United States Average Annual Cost of Diagnosis and

Treatment of Autoimmune Disorders, 2014

Sample Data - Snapshot

© Pharmaion

1 2 3 4 5 7 8 9 10 11 12

2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F

United States Autoimmune Disorders Diagnostics

Market Size, By Value, 2010-2020F (USD Billion)

3.00% 3.0… 3.02% 3.03% 3.04% 3.05% 3.06% 3.07% 3.08% 3.09% 3.10%

6.00% 6.01% 6.02% 6.03% 6.04% 6.05% 6.06% 6.07% 6.08% 6.09% 6.10%8.00% 8.01% 8.02% 8.03% 8.04% 8.05% 8.06% 8.07% 8.08% 8.09% 8.10%

9.00% 9.01% 9.02% 9.03% 9.04% 9.05% 9.06% 9.07% 9.08% 9.09% 9.10%

14.00% 14.01% 14.02% 14.03% 14.04% 14.05% 14.06% 14.07% 14.08% 14.09% 14.10%

17.00% 17.01% 17.02% 17.03% 17.04% 17.05% 17.06% 17.07% 17.08% 17.09% 17.10%

35.00% 35.01% 35.02% 35.03% 35.04% 35.05% 35.06% 35.07% 35.08% 35.09% 35.10%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Anti-Nuclear Ant ibody Test Complete Blood Count (CBC)Erythrocyte Sedimentation Rate (ESR) C-reactive Protein

United States Autoimmune Disorders Diagnostics Market Share, By Test,

By Value, 2010-2020F

MidwestWest

North-East

South-West

South-East

2014: X%2020F: X%

2014: X%

2020F: X%2014: X%2020F: X%

2014: X%2020F: X%

2014: X%2020F: X%

United States Autoimmune Disorders Diagnosis Market

Share, By Region, By Value, 2014 & 2020F

ClinicalDiagnosti

cs,50.00%

Life

Science,50.00%

OtherCountries,50.00%

Unites

States,50.00%

SEGMENTAL REVENUE BREAK UP, 2014By Business Segments By Geography


http://slidepdf.com/reader/full/united-states-autoimmune-disorders-diagnostics-market-report 10/11©

10

R e p o r t O r d e r i n g

License Type Price

Single User License $3000

Single User License Print $3500

Enterprise License $5000

To View Sample OR Purchase Report

Report Price

Report Name: United States Autoimmune Disorders Diagnostics Market

Opportunities, 2020

http://www.pharmaion.com/report/united-states-autoimmune-disorders-diagnostics-market-opportunities-2020/19.html

http://www.pharmaion.com/report/united-states-autoimmune-disorders-diagnostics-market-opportunities-2020/19.html



A b o u t U s & D i s c l a i m e r

11

NORTH AMERICA

Pharmaion Consultants LLC

708 3RD Avenue, 6th Floor, New York, NY,

United State, 10017

[email protected]

+1 646 360 1656www.pharmaion.com

About Us :

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.

Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customerswith high value market research and advisory services that helps them identify new market opportunities, growth engines andinnovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound bylegacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology asengines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reportsdo not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trainedindustry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consultingrequirements.

Related Reports

India Stem Cell Market Opportunities, 2020

Global Tissue Engineered Medical Devices Market Opportunities, 2020

Global Cervical Cancer Vaccine Market Opportunities, 2020

Disclaimer :The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made

that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained fromvarious sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy orcompleteness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information andespecially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimatesand forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’sinternal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.

ASIA PACIFIC

Pharmaion Consultants Pvt. Ltd.

A – 51, Sector 57, Noida, National Capital Region,

India - 201301

[email protected]

+91 - 120 - 452 3900www.pharmaion.com © Pharmaion

Documents

United States Autoimmune Disorders Diagnostics Market Report